Grünenthal presents Phase III results for Qutenza® in postoperative neuropathic pain at the IASP 2026 World Congress on Pain

Summary

Late breakdown data from the Phase III RISE trial further strengthen the well-established efficacy and safety profile of Qutenza®. Post-surgical neuropathic pain is a debilitating complication of surgery affecting mill...